Oura Files for IPO as Smart Ring Market Heats Up
The health-tracking pioneer seeks a public listing with $1.21 billion in recent revenue amid rising competition.
Oura officially filed to go public on September 3, 2026, marking a pivotal moment for the wearable health industry. The move comes as the company attempts to solidify its lead in a rapidly crowding smart ring market.
The filing follows a period of aggressive financial growth. Oura reported revenue of $1.21 billion for the nine months ended June 30, nearly doubling its performance from the previous year. The company sold 3.6 million rings over the past twelve months and currently maintains a base of approximately 5 million paid members. Oura is targeting a valuation exceeding $16 billion as it transitions to a public entity.
The Battle for the Finger
For years, Oura has dominated the category by focusing on high-accuracy sleep and health monitoring, most recently evidenced by the launch of the Oura Ring 5. However, the competitive landscape is shifting. Rivals including Samsung, Ultrahuman, Circular, and RingConn are now challenging Oura's dominance by attempting to evolve the device from a passive monitor into a more functional tool.
Some competitors are pushing for "mini-smartphone" capabilities. Ultrahuman, for instance, raised $70 million with backing from Qualcomm to develop rings capable of running software directly on the device. Other market players are exploring the integration of haptic alerts and contactless payments to differentiate their offerings from Oura's health-centric approach.
Defending the Moat
Oura has not relied solely on product iterations to maintain its market share. The company has actively used patent litigation to protect its intellectual property. This strategy saw a significant victory in May 2025, when Oura won an initial determination against Ultrahuman in a U.S. International Trade Commission (ITC) patent infringement case.
Market Implications
This IPO serves as a critical litmus test for investors. The primary question is whether public markets will value hardware-anchored health products at the high multiples typically reserved for software companies.
Furthermore, the industry faces a conceptual crossroads. As competitors race to add screens, touchpads, and payment systems, there is a risk of undermining the core appeal of the smart ring: its unobtrusiveness. If rings become too complex, they may lose the primary advantage they hold over the ubiquitous smartwatch.
What to Watch
Investors will be watching closely to see if Oura's subscription-heavy business model can sustain its growth trajectory post-IPO. While the company's revenue surge is impressive, the entry of tech giants like Samsung suggests that the cost of customer acquisition may rise. It remains to be seen if Oura can maintain its premium positioning while rivals introduce more diverse, on-device functionality.